Cure My Disease

Don't miss your cure!

 Log in / Sign up

At-Home HPV test kit aims to boost cervical cancer screening in underserved women

NCT ID NCT06577220

Ongoing Prevention Sponsor: Baylor College of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether mailing a self-sampling HPV test kit to Asian and underserved women can increase cervical cancer screening rates. Participants receive a kit to collect a sample at home and send it back for testing, along with phone support. The goal is to make screening easier for those who cannot or do not attend clinic appointments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Mailed HPV self-sampling kit
What this could lead to
If successful, this approach could make cervical cancer screening easier and more accessible for women who avoid or miss clinic visits.
What could go wrong
This is a small, early-stage trial with only 111 participants. The at-home test may not be as accurate as a clinic Pap test, and some women may still not return the kit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer human papilloma virus infection Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HUMAN PAPILLOMAVIRUS INFECTION

Contacts and locations

Locations

  • Harris Health System

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.